BioNTech SE

11/19/2021 | Press release | Distributed by Public on 11/19/2021 07:28

Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older